Trevi Therapeutics, Inc. (TRVI) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Trevi Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.520 -- 00:00:05.826 Good afternoon, and welcome to the Trevi Therapeutics second quarter 2025 00:00:05.826 -- 00:00:10.831 earnings conference call. At this time, all participants will be 00:00:10.831 -- 00:00:16.837 in listen-only mode. Should you need assistance, please signal a conference specialist 00:00:16.837 -- 00:00:20.361 by pressing the star key followed by zero. 00:00:20.361 -- 00:00:25.726 After today's presentation, there will be an opportunity to ask questions. 00:00:25.726 -- 00:00:31.182 To ask a question, you may press star, then one on your telephone. 00:00:31.182 -- 00:00:36.267 To withdraw your question, please press star, then two. 00:00:36.267 -- 00:00:40.309 Please note this event is being recorded. 00:00:40.632 -- 00:00:45.557 Various remarks that management makes during this conference call about the company's 00:00:45.557 -- 00:00:47.459 future expectations, 00:00:47.459 -- 00:00:52.584 plans, and prospects constitute forward-looking statements for purposes 00:00:52.584 -- 00:00:55.047 of the safe harbor provisions 00:00:55.047 -- 00:01:00.663 under the Private Securities Litigation Reform Act of 1995. 00:01:00.663 -- 00:01:06.128 Actual results may differ materially from those indicated by these forward-looking 00:01:06.128 -- 00:01:11.233 statements as a result of various important factors, including 00:01:11.233 -- 00:01:16.858 those discussed in the risk factor section of the company's most recent quarterly report 00:01:16.858 -- 00:01:23.004 on Form 10-Q, which the company filed with the SEC this afternoon. 00:01:23.004 -- 00:01:28.249 In addition, any forward-looking statements represent the company's views 00:01:28.249 -- 00:01:34.051 only as of today and should not be relied upon as representing the company's views 00...